108 related articles for article (PubMed ID: 21475251)
1. ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia.
Otto N; Manukjan G; Göhring G; Hofmann W; Scherer R; Luna JC; Lehmann U; Ganser A; Welte K; Schlegelberger B; Steinemann D
Leukemia; 2011 Jul; 25(7):1202-7. PubMed ID: 21475251
[No Abstract] [Full Text] [Related]
2. Bone marrow cells of myelodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia.
Abe S; Yamamoto K; Hasegawa M; Inoue M; Kurata M; Hirokawa K; Kitagawa M; Nakagawa Y; Suzuki K
Leuk Res; 2005 Sep; 29(9):1095-6. PubMed ID: 16038738
[No Abstract] [Full Text] [Related]
3. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
4. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
Karlic H; Herrmann H; Varga F; Thaler R; Reitermaier R; Spitzer S; Ghanim V; Blatt K; Sperr WR; Valent P; Pfeilstöcker M
Crit Rev Oncol Hematol; 2014 Apr; 90(1):1-16. PubMed ID: 24183913
[TBL] [Abstract][Full Text] [Related]
5. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling.
Flach J; Dicker F; Schnittger S; Schindela S; Kohlmann A; Haferlach T; Kern W; Haferlach C
Leukemia; 2011 Apr; 25(4):713-8. PubMed ID: 21233836
[No Abstract] [Full Text] [Related]
6. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
7. Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
Treppendahl MB; Möllgård L; Hellström-Lindberg E; Cloos P; Grønbaek K
Eur J Haematol; 2013 Mar; 90(3):259-60. PubMed ID: 23190153
[No Abstract] [Full Text] [Related]
8. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
9. Absence of p300 gene promoter methylation in acute leukemia.
Chim CS; Wong AS; Kwong YL
Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
11. Trisomy 11: prevalence among 22,403 unique patient cytogenetic studies and clinical correlates.
Caramazza D; Ketterling RP; Knudson RA; Hanson CA; Siragusa S; Pardanani A; Tefferi A
Leukemia; 2010 May; 24(5):1092-4. PubMed ID: 20357821
[No Abstract] [Full Text] [Related]
12. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
13. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
Bains A; Luthra R; Medeiros LJ; Zuo Z
Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
[TBL] [Abstract][Full Text] [Related]
14. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
15. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
Schildgen V; Wulfert M; Gattermann N
Exp Hematol; 2011 Jun; 39(6):666-675.e1. PubMed ID: 21447369
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.
Layton DM; Mufti GJ
Blut; 1986 Dec; 53(6):423-36. PubMed ID: 3542084
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
[TBL] [Abstract][Full Text] [Related]
18. [Importance of cytogenetics in the study of acute non-lymphoblastic leukemias].
Prieto F; Badía L; Palau F; Beneyto M; Montero MR; Martínez-Castellano F
Sangre (Barc); 1991 Jun; 36(3):229-35. PubMed ID: 1948543
[No Abstract] [Full Text] [Related]
19. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
[TBL] [Abstract][Full Text] [Related]
20. [Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia].
Liang T; Tan T; Xiao Y; Yi H; Li C; Peng F; Chen Z; Xiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):388-94. PubMed ID: 19483285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
